 | • レポートコード：QYR2104Z4644 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、プラスミドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（F-プラスミド、Colプラスミド、耐性プラスミド、陰性プラスミド、分解性プラスミド、病原性プラスミド）、用途別市場規模（トランスフェクション、組換えDNA技術、遺伝子治療、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・プラスミドの市場動向 ・企業の競争状況、市場シェア ・プラスミドの種類別市場規模（F-プラスミド、Colプラスミド、耐性プラスミド、陰性プラスミド、分解性プラスミド、病原性プラスミド） ・プラスミドの用途別市場規模（トランスフェクション、組換えDNA技術、遺伝子治療、その他） ・プラスミドの北米市場規模2016-2027（アメリカ、カナダ） ・プラスミドのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・プラスミドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・プラスミドの中南米市場規模2016-2027（メキシコ、ブラジル） ・プラスミドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aldevron、GenScript、PlasmidFactory GmbH & Co. KG、VGXI Inc.、Oxford Genetics Ltd.、Applied StemCell、Altogen Biosystems、Cobra Biologics、Copernicus Therapeutics Inc.、Takara Bio、InvivoGen、Miltenyi Biotec、Medigene Sdn Bhd、MaxCyte Inc.、Mirus Bio LLC、MolMed S.p.A.、GenePharma、Polyplus Transfection） ・結論 |
Market Analysis and Insights: Global Plasmid Market
The global Plasmid market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasmid market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasmid market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasmid market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasmid market.
Global Plasmid Scope and Market Size
Plasmid market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasmid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
F-Plasmids
Col Plasmids
Resistance Plasmids
Cryptic Plasmids
Degradative Plasmids
Virulence Plasmids
Segment by Application
Transfection
Recombinant DNA Technology
Gene Therapy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Aldevron
GenScript
PlasmidFactory GmbH & Co. KG
VGXI Inc.
Oxford Genetics Ltd.
Applied StemCell
Altogen Biosystems
Cobra Biologics
Copernicus Therapeutics Inc.
Takara Bio
InvivoGen
Miltenyi Biotec
Medigene Sdn Bhd
MaxCyte Inc.
Mirus Bio LLC
MolMed S.p.A.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 F-Plasmids
1.2.3 Col Plasmids
1.2.4 Resistance Plasmids
1.2.5 Cryptic Plasmids
1.2.6 Degradative Plasmids
1.2.7 Virulence Plasmids
1.3 Market by Application
1.3.1 Global Plasmid Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Transfection
1.3.3 Recombinant DNA Technology
1.3.4 Gene Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Market Perspective (2016-2027)
2.2 Plasmid Growth Trends by Regions
2.2.1 Plasmid Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plasmid Historic Market Share by Regions (2016-2021)
2.2.3 Plasmid Forecasted Market Size by Regions (2022-2027)
2.3 Plasmid Industry Dynamic
2.3.1 Plasmid Market Trends
2.3.2 Plasmid Market Drivers
2.3.3 Plasmid Market Challenges
2.3.4 Plasmid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Players by Revenue
3.1.1 Global Top Plasmid Players by Revenue (2016-2021)
3.1.2 Global Plasmid Revenue Market Share by Players (2016-2021)
3.2 Global Plasmid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plasmid Revenue
3.4 Global Plasmid Market Concentration Ratio
3.4.1 Global Plasmid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Revenue in 2020
3.5 Plasmid Key Players Head office and Area Served
3.6 Key Players Plasmid Product Solution and Service
3.7 Date of Enter into Plasmid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Breakdown Data by Type
4.1 Global Plasmid Historic Market Size by Type (2016-2021)
4.2 Global Plasmid Forecasted Market Size by Type (2022-2027)
5 Plasmid Breakdown Data by Application
5.1 Global Plasmid Historic Market Size by Application (2016-2021)
5.2 Global Plasmid Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Plasmid Market Size (2016-2027)
6.2 North America Plasmid Market Size by Type
6.2.1 North America Plasmid Market Size by Type (2016-2021)
6.2.2 North America Plasmid Market Size by Type (2022-2027)
6.2.3 North America Plasmid Market Size by Type (2016-2027)
6.3 North America Plasmid Market Size by Application
6.3.1 North America Plasmid Market Size by Application (2016-2021)
6.3.2 North America Plasmid Market Size by Application (2022-2027)
6.3.3 North America Plasmid Market Size by Application (2016-2027)
6.4 North America Plasmid Market Size by Country
6.4.1 North America Plasmid Market Size by Country (2016-2021)
6.4.2 North America Plasmid Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Plasmid Market Size (2016-2027)
7.2 Europe Plasmid Market Size by Type
7.2.1 Europe Plasmid Market Size by Type (2016-2021)
7.2.2 Europe Plasmid Market Size by Type (2022-2027)
7.2.3 Europe Plasmid Market Size by Type (2016-2027)
7.3 Europe Plasmid Market Size by Application
7.3.1 Europe Plasmid Market Size by Application (2016-2021)
7.3.2 Europe Plasmid Market Size by Application (2022-2027)
7.3.3 Europe Plasmid Market Size by Application (2016-2027)
7.4 Europe Plasmid Market Size by Country
7.4.1 Europe Plasmid Market Size by Country (2016-2021)
7.4.2 Europe Plasmid Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Market Size (2016-2027)
8.2 Asia-Pacific Plasmid Market Size by Type
8.2.1 Asia-Pacific Plasmid Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plasmid Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plasmid Market Size by Type (2016-2027)
8.3 Asia-Pacific Plasmid Market Size by Application
8.3.1 Asia-Pacific Plasmid Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plasmid Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plasmid Market Size by Application (2016-2027)
8.4 Asia-Pacific Plasmid Market Size by Region
8.4.1 Asia-Pacific Plasmid Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plasmid Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasmid Market Size (2016-2027)
9.2 Latin America Plasmid Market Size by Type
9.2.1 Latin America Plasmid Market Size by Type (2016-2021)
9.2.2 Latin America Plasmid Market Size by Type (2022-2027)
9.2.3 Latin America Plasmid Market Size by Type (2016-2027)
9.3 Latin America Plasmid Market Size by Application
9.3.1 Latin America Plasmid Market Size by Application (2016-2021)
9.3.2 Latin America Plasmid Market Size by Application (2022-2027)
9.3.3 Latin America Plasmid Market Size by Application (2016-2027)
9.4 Latin America Plasmid Market Size by Country
9.4.1 Latin America Plasmid Market Size by Country (2016-2021)
9.4.2 Latin America Plasmid Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Market Size (2016-2027)
10.2 Middle East & Africa Plasmid Market Size by Type
10.2.1 Middle East & Africa Plasmid Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plasmid Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plasmid Market Size by Type (2016-2027)
10.3 Middle East & Africa Plasmid Market Size by Application
10.3.1 Middle East & Africa Plasmid Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plasmid Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plasmid Market Size by Application (2016-2027)
10.4 Middle East & Africa Plasmid Market Size by Country
10.4.1 Middle East & Africa Plasmid Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plasmid Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aldevron
11.1.1 Aldevron Company Details
11.1.2 Aldevron Business Overview
11.1.3 Aldevron Plasmid Introduction
11.1.4 Aldevron Revenue in Plasmid Business (2016-2021)
11.1.5 Aldevron Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript Plasmid Introduction
11.2.4 GenScript Revenue in Plasmid Business (2016-2021)
11.2.5 GenScript Recent Development
11.3 PlasmidFactory GmbH & Co. KG
11.3.1 PlasmidFactory GmbH & Co. KG Company Details
11.3.2 PlasmidFactory GmbH & Co. KG Business Overview
11.3.3 PlasmidFactory GmbH & Co. KG Plasmid Introduction
11.3.4 PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2016-2021)
11.3.5 PlasmidFactory GmbH & Co. KG Recent Development
11.4 VGXI Inc.
11.4.1 VGXI Inc. Company Details
11.4.2 VGXI Inc. Business Overview
11.4.3 VGXI Inc. Plasmid Introduction
11.4.4 VGXI Inc. Revenue in Plasmid Business (2016-2021)
11.4.5 VGXI Inc. Recent Development
11.5 Oxford Genetics Ltd.
11.5.1 Oxford Genetics Ltd. Company Details
11.5.2 Oxford Genetics Ltd. Business Overview
11.5.3 Oxford Genetics Ltd. Plasmid Introduction
11.5.4 Oxford Genetics Ltd. Revenue in Plasmid Business (2016-2021)
11.5.5 Oxford Genetics Ltd. Recent Development
11.6 Applied StemCell
11.6.1 Applied StemCell Company Details
11.6.2 Applied StemCell Business Overview
11.6.3 Applied StemCell Plasmid Introduction
11.6.4 Applied StemCell Revenue in Plasmid Business (2016-2021)
11.6.5 Applied StemCell Recent Development
11.7 Altogen Biosystems
11.7.1 Altogen Biosystems Company Details
11.7.2 Altogen Biosystems Business Overview
11.7.3 Altogen Biosystems Plasmid Introduction
11.7.4 Altogen Biosystems Revenue in Plasmid Business (2016-2021)
11.7.5 Altogen Biosystems Recent Development
11.8 Cobra Biologics
11.8.1 Cobra Biologics Company Details
11.8.2 Cobra Biologics Business Overview
11.8.3 Cobra Biologics Plasmid Introduction
11.8.4 Cobra Biologics Revenue in Plasmid Business (2016-2021)
11.8.5 Cobra Biologics Recent Development
11.9 Copernicus Therapeutics Inc.
11.9.1 Copernicus Therapeutics Inc. Company Details
11.9.2 Copernicus Therapeutics Inc. Business Overview
11.9.3 Copernicus Therapeutics Inc. Plasmid Introduction
11.9.4 Copernicus Therapeutics Inc. Revenue in Plasmid Business (2016-2021)
11.9.5 Copernicus Therapeutics Inc. Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Plasmid Introduction
11.10.4 Takara Bio Revenue in Plasmid Business (2016-2021)
11.10.5 Takara Bio Recent Development
11.11 InvivoGen
11.11.1 InvivoGen Company Details
11.11.2 InvivoGen Business Overview
11.11.3 InvivoGen Plasmid Introduction
11.11.4 InvivoGen Revenue in Plasmid Business (2016-2021)
11.11.5 InvivoGen Recent Development
11.12 Miltenyi Biotec
11.12.1 Miltenyi Biotec Company Details
11.12.2 Miltenyi Biotec Business Overview
11.12.3 Miltenyi Biotec Plasmid Introduction
11.12.4 Miltenyi Biotec Revenue in Plasmid Business (2016-2021)
11.12.5 Miltenyi Biotec Recent Development
11.13 Medigene Sdn Bhd
11.13.1 Medigene Sdn Bhd Company Details
11.13.2 Medigene Sdn Bhd Business Overview
11.13.3 Medigene Sdn Bhd Plasmid Introduction
11.13.4 Medigene Sdn Bhd Revenue in Plasmid Business (2016-2021)
11.13.5 Medigene Sdn Bhd Recent Development
11.14 MaxCyte Inc.
11.14.1 MaxCyte Inc. Company Details
11.14.2 MaxCyte Inc. Business Overview
11.14.3 MaxCyte Inc. Plasmid Introduction
11.14.4 MaxCyte Inc. Revenue in Plasmid Business (2016-2021)
11.14.5 MaxCyte Inc. Recent Development
11.15 Mirus Bio LLC
11.15.1 Mirus Bio LLC Company Details
11.15.2 Mirus Bio LLC Business Overview
11.15.3 Mirus Bio LLC Plasmid Introduction
11.15.4 Mirus Bio LLC Revenue in Plasmid Business (2016-2021)
11.15.5 Mirus Bio LLC Recent Development
11.16 MolMed S.p.A.
11.16.1 MolMed S.p.A. Company Details
11.16.2 MolMed S.p.A. Business Overview
11.16.3 MolMed S.p.A. Plasmid Introduction
11.16.4 MolMed S.p.A. Revenue in Plasmid Business (2016-2021)
11.16.5 MolMed S.p.A. Recent Development
11.17 GenePharma
11.17.1 GenePharma Company Details
11.17.2 GenePharma Business Overview
11.17.3 GenePharma Plasmid Introduction
11.17.4 GenePharma Revenue in Plasmid Business (2016-2021)
11.17.5 GenePharma Recent Development
11.18 Polyplus Transfection
11.18.1 Polyplus Transfection Company Details
11.18.2 Polyplus Transfection Business Overview
11.18.3 Polyplus Transfection Plasmid Introduction
11.18.4 Polyplus Transfection Revenue in Plasmid Business (2016-2021)
11.18.5 Polyplus Transfection Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Plasmid Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of F-Plasmids
Table 3. Key Players of Col Plasmids
Table 4. Key Players of Resistance Plasmids
Table 5. Key Players of Cryptic Plasmids
Table 6. Key Players of Degradative Plasmids
Table 7. Key Players of Virulence Plasmids
Table 8. Global Plasmid Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Plasmid Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Plasmid Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Plasmid Market Share by Regions (2016-2021)
Table 12. Global Plasmid Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Plasmid Market Share by Regions (2022-2027)
Table 14. Plasmid Market Trends
Table 15. Plasmid Market Drivers
Table 16. Plasmid Market Challenges
Table 17. Plasmid Market Restraints
Table 18. Global Plasmid Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Plasmid Market Share by Players (2016-2021)
Table 20. Global Top Plasmid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasmid as of 2020)
Table 21. Ranking of Global Top Plasmid Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Plasmid Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Plasmid Product Solution and Service
Table 25. Date of Enter into Plasmid Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasmid Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Plasmid Revenue Market Share by Type (2016-2021)
Table 29. Global Plasmid Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Plasmid Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Plasmid Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Plasmid Revenue Market Share by Application (2016-2021)
Table 33. Global Plasmid Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Plasmid Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Plasmid Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Plasmid Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Plasmid Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Plasmid Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Plasmid Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Plasmid Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Plasmid Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Plasmid Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Plasmid Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Plasmid Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Plasmid Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Plasmid Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Plasmid Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Plasmid Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Plasmid Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Plasmid Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Plasmid Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Plasmid Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Plasmid Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Plasmid Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Plasmid Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Plasmid Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Plasmid Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Plasmid Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Plasmid Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Plasmid Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Plasmid Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Plasmid Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Plasmid Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Plasmid Market Size by Country (2022-2027) & (US$ Million)
Table 65. Aldevron Company Details
Table 66. Aldevron Business Overview
Table 67. Aldevron Plasmid Product
Table 68. Aldevron Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 69. Aldevron Recent Development
Table 70. GenScript Company Details
Table 71. GenScript Business Overview
Table 72. GenScript Plasmid Product
Table 73. GenScript Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 74. GenScript Recent Development
Table 75. PlasmidFactory GmbH & Co. KG Company Details
Table 76. PlasmidFactory GmbH & Co. KG Business Overview
Table 77. PlasmidFactory GmbH & Co. KG Plasmid Product
Table 78. PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 79. PlasmidFactory GmbH & Co. KG Recent Development
Table 80. VGXI Inc. Company Details
Table 81. VGXI Inc. Business Overview
Table 82. VGXI Inc. Plasmid Product
Table 83. VGXI Inc. Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 84. VGXI Inc. Recent Development
Table 85. Oxford Genetics Ltd. Company Details
Table 86. Oxford Genetics Ltd. Business Overview
Table 87. Oxford Genetics Ltd. Plasmid Product
Table 88. Oxford Genetics Ltd. Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 89. Oxford Genetics Ltd. Recent Development
Table 90. Applied StemCell Company Details
Table 91. Applied StemCell Business Overview
Table 92. Applied StemCell Plasmid Product
Table 93. Applied StemCell Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 94. Applied StemCell Recent Development
Table 95. Altogen Biosystems Company Details
Table 96. Altogen Biosystems Business Overview
Table 97. Altogen Biosystems Plasmid Product
Table 98. Altogen Biosystems Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 99. Altogen Biosystems Recent Development
Table 100. Cobra Biologics Company Details
Table 101. Cobra Biologics Business Overview
Table 102. Cobra Biologics Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 103. Cobra Biologics Recent Development
Table 104. Copernicus Therapeutics Inc. Company Details
Table 105. Copernicus Therapeutics Inc. Business Overview
Table 106. Copernicus Therapeutics Inc. Plasmid Product
Table 107. Copernicus Therapeutics Inc. Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 108. Copernicus Therapeutics Inc. Recent Development
Table 109. Takara Bio Company Details
Table 110. Takara Bio Business Overview
Table 111. Takara Bio Plasmid Product
Table 112. Takara Bio Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 113. Takara Bio Recent Development
Table 114. InvivoGen Company Details
Table 115. InvivoGen Business Overview
Table 116. InvivoGen Plasmid Product
Table 117. InvivoGen Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 118. InvivoGen Recent Development
Table 119. Miltenyi Biotec Company Details
Table 120. Miltenyi Biotec Business Overview
Table 121. Miltenyi Biotec Plasmid Product
Table 122. Miltenyi Biotec Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 123. Miltenyi Biotec Recent Development
Table 124. Medigene Sdn Bhd Company Details
Table 125. Medigene Sdn Bhd Business Overview
Table 126. Medigene Sdn Bhd Plasmid Product
Table 127. Medigene Sdn Bhd Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 128. Medigene Sdn Bhd Recent Development
Table 129. MaxCyte Inc. Company Details
Table 130. MaxCyte Inc. Business Overview
Table 131. MaxCyte Inc. Plasmid Product
Table 132. MaxCyte Inc. Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 133. MaxCyte Inc. Recent Development
Table 134. Mirus Bio LLC Company Details
Table 135. Mirus Bio LLC Business Overview
Table 136. Mirus Bio LLC Plasmid Product
Table 137. Mirus Bio LLC Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 138. Mirus Bio LLC Recent Development
Table 139. MolMed S.p.A. Company Details
Table 140. MolMed S.p.A. Business Overview
Table 141. MolMed S.p.A. Plasmid Product
Table 142. MolMed S.p.A. Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 143. MolMed S.p.A. Recent Development
Table 144. GenePharma Company Details
Table 145. GenePharma Business Overview
Table 146. GenePharma Plasmid Product
Table 147. GenePharma Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 148. GenePharma Recent Development
Table 149. Polyplus Transfection Company Details
Table 150. Polyplus Transfection Business Overview
Table 151. Polyplus Transfection Plasmid Product
Table 152. Polyplus Transfection Revenue in Plasmid Business (2016-2021) & (US$ Million)
Table 153. Polyplus Transfection Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasmid Market Share by Type: 2020 VS 2027
Figure 2. F-Plasmids Features
Figure 3. Col Plasmids Features
Figure 4. Resistance Plasmids Features
Figure 5. Cryptic Plasmids Features
Figure 6. Degradative Plasmids Features
Figure 7. Virulence Plasmids Features
Figure 8. Global Plasmid Market Share by Application: 2020 VS 2027
Figure 9. Transfection Case Studies
Figure 10. Recombinant DNA Technology Case Studies
Figure 11. Gene Therapy Case Studies
Figure 12. Others Case Studies
Figure 13. Plasmid Report Years Considered
Figure 14. Global Plasmid Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Plasmid Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Plasmid Market Share by Regions: 2020 VS 2027
Figure 17. Global Plasmid Market Share by Regions (2022-2027)
Figure 18. Global Plasmid Market Share by Players in 2020
Figure 19. Global Top Plasmid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasmid as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Plasmid Revenue in 2020
Figure 21. Global Plasmid Revenue Market Share by Type (2016-2021)
Figure 22. Global Plasmid Revenue Market Share by Type (2022-2027)
Figure 23. North America Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Plasmid Market Share by Type (2016-2027)
Figure 25. North America Plasmid Market Share by Application (2016-2027)
Figure 26. North America Plasmid Market Share by Country (2016-2027)
Figure 27. United States Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Plasmid Market Share by Type (2016-2027)
Figure 31. Europe Plasmid Market Share by Application (2016-2027)
Figure 32. Europe Plasmid Market Share by Country (2016-2027)
Figure 33. Germany Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Plasmid Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Plasmid Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Plasmid Market Share by Region (2016-2027)
Figure 43. China Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Plasmid Market Share by Type (2016-2027)
Figure 51. Latin America Plasmid Market Share by Application (2016-2027)
Figure 52. Latin America Plasmid Market Share by Country (2016-2027)
Figure 53. Mexico Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Plasmid Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Plasmid Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Plasmid Market Share by Country (2016-2027)
Figure 59. Turkey Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Plasmid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Aldevron Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 63. GenScript Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 64. PlasmidFactory GmbH & Co. KG Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 65. VGXI Inc. Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 66. Oxford Genetics Ltd. Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 67. Applied StemCell Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 68. Altogen Biosystems Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 69. Cobra Biologics Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 70. Copernicus Therapeutics Inc. Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 71. Takara Bio Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 72. InvivoGen Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 73. Miltenyi Biotec Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 74. Medigene Sdn Bhd Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 75. MaxCyte Inc. Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 76. Mirus Bio LLC Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 77. MolMed S.p.A. Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 78. GenePharma Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 79. Polyplus Transfection Revenue Growth Rate in Plasmid Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界のウイルスベクター＆プラスミドDNA市場規模・現状・予測（2021年-2027年） Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory …- 世界のウイルスベクター＆プラスミドDNA製造市場規模・現状・予測（2021年-2027年） The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accoun…
- 世界のムコ多糖症遺伝子治療市場規模・現状・予測（2021年-2027年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…